IL17A and acute promyelocytic leukemia: Therefore, it is suggested that increased production of IL-17A leads to an increased risk of early hemorrhagic death in newly diagnosed APL patients by inducing TF overexpression to initiate coagulation and further leading to the excessive depletion of clotting factors.